Search

everythinglearnresearchcommunity

for

Search:↓

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

A group has developed therapies that show promise for treating cancer and various other conditions.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Effective treatments for severe alopecia areata are still lacking.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Activating Nrf2 protects human hair follicles from oxidative stress and helps prevent hair growth inhibition.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Permanent hair dye mixtures can irritate and damage the skin.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

A 308 nm excimer laser successfully treated a boy with a rare skin condition after about a year of weekly sessions.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.